Evidence, technology and equity: rethinking diabetes care in pregnancy

Diabetes during pregnancy – whether pre-existing or first diagnosed in pregnancy – affects millions of women worldwide and poses a significant clinical and public health challenge. Although most women deliver healthy infants, maternal dysglycaemia is associated with preventable short- and long-term complications for both mother and child, highlighting the importance of timely, coordinated and evidence-based care across preconception, pregnancy, and the postpartum period. Improving care for diabetes in pregnancy calls for a multifaceted approach. This approach includes strong evidence, effective care models, healthcare system readiness and equitable access to essential tools. Clinical guidance and supportive policies also underpin better management of diabetes during pregnancy. At the core are diabetes technologies, as emphasised in an International Consensus Statement – endorsed by the IDF and 23 professional societies – which supports the use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) for pregnant women with type 1, type 2 or gestational diabetes. This IDF webinar will bring together healthcare professionals and female advocates to examine current evidence, discuss global priorities in diabetes care during pregnancy, and consider the role of technology. Together, they will explore practical and policy approaches to advance equitable, high-quality care for women before, during and after pregnancy.